Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: Results after three years

Transplantation

Volumn 75, Issue 4, 2003, Pages 454-461

  Jungraithmayr, Therese ^a   Staskewitz, Astrid ^a   Kirste, Günter ^b   Böswald, Michael ^c   Bulla, Monika ^d   Burghard, Rainer ^e   Dippell, Jürgen ^f   Greiner, Christel ^g   Helmchen, Udo ^h   Klare, Bernd ⁱ   Klaus, Günter ^j   Leichter, Heinz E ^k   Mihatsch, Michael J ^l   Michalk, Dietrich V ^m   Misselwitz, Joachim ⁿ   Plank, Christian ^c   Querfeld, Uwe ^m   Weber, Lutz T ^o   Wiesel, Manfred ^p   Tönshoff, Burkhard ^o   Zimmerhackl, Lothar B ^a,q   more..

^a Ztr fur Kinderheilkunde/Jugendmed   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^e Kinderklinik   (Germany)

^f Clementine Kinderhospital   (Germany)

^g Klinikum St Georg   (Germany)

^h UNIVERSITY OF HAMBURG   (Germany)

ⁱ Department of Software and Systems Engineering   (Germany)

^j UNIVERSITY HOSPITAL MARBURG   (Germany)

^k OLGAHOSPITAL   (Germany)

^l UNIVERSITY HOSPITAL BASEL   (Switzerland)

^m UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

ⁿ JENA UNIVERSITY HOSPITAL   (Germany)

^o UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^p UNIVERSITY OF HEIDELBERG   (Germany)

^q UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CREATININE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADOLESCENT; ARTERIAL PRESSURE; ARTICLE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; CREATININE CLEARANCE; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GRAFT REJECTION; GRAFT SURVIVAL; HALF LIFE TIME; HERPES SIMPLEX; HODGKIN DISEASE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVER TOXICITY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SURVIVAL TIME; THRUSH; TIME SERIES ANALYSIS; TREATMENT OUTCOME; URINARY TRACT INFECTION; VERTIGO; WART VIRUS;

ACUTE DISEASE; ADOLESCENT; AZATHIOPRINE; BLOOD PRESSURE; CHILD; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MYCOPHENOLIC ACID; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0037468452     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000045748.95874.64     Document Type: Article

References (30)

1. Elshihabi I, Chavers B, Donaldson L, et al. Continuing improvement in cadaver donor graft survival in North American children: the 1998 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 2000; 4: 235-246.
2. Gulanikar AC, MacDonald AS, Sungertekin U, et al. The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants. Transplantation 1992; 53: 323-328.
3. Matas AJ. Impact of acute rejection on development of chronic rejection in pediatric renal transplant recipients. Pediatr Transplantation 2000; 4: 92-99.
4. Tejani A, Sullivan EK. The impact of acute rejection on chronic rejection: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2000; 4: 107-111.
5. Allison AC, Eugui EM. The design and development of an immunosuppressive drug, mycophenolate mofetil. Springer Semin Immunopathol 1993; 14: 353-380.
6. Allison AC, Eugui EM. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant 1996; 10: 77-84.
7. Sollinger HW for the US Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995; 60: 225-232.
8. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995; 345: 1321-1325.
9. Tricontinetal Mycophenolate Mofetil Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996; 61: 1029-1037.
10. Halloran P, Mathew T, Tomlanovich S, et al, for the International Mycophenolate Mofetil Renal Transplant Study Groups. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. Transplantation 1997; 63: 39-47.
11. Wüthrich RP, Weinreich T, Ambühl PM, et al. Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil. Nephrol Dial Transplant 1999; 14: 394-399.
12. Staskewitz A, Kirste G, Tonshoff B, et al. Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. German Pediatric Renal Transplantation Study Group. Transplantation. 2001; 71: 638-644.
13. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, long term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation. Transplantation 1998; 65: 1450-1454.
14. US Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil in cadaveric renal transplantation. Am J Kid Dis 1999; 34: 296-303.
15. European Mycophenolate Mofetil Cooperative Study Group. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. Transplantation 1999; 68: 391-396.
16. Neu AM, Benfield M. What is the role for mycophenolate mofetil in pediatric renal transplantation? Pediatr Transplant 1999; 3: 83-87.
17. Weber LT, Shipkova M, Lamersdorf T, et al. Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in paediatric and adult renal transplant recipients. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients. J Am Soc Nephrol 1998; 9(8): 1511-1520.
18. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605-612.
19. Schwartz GJ, Haycock GB, Edelmann CM Jr, et al. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58(2): 259-263.
20. Cransberg K, van Gool JD, Davin C, et al. Pediatric renal transplantation in the Netherlands. Pediatr Transplant 2000; 4: 72-81.
21. Seikaly M, Ho PL, Emmett L, et al. The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: renal transplantation from 1987 through 1998. Pediatr Transplant 2001; 5: 215-231.
22. Ho M, Stablein DM for the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). 2002 Annual report: Renal transplantation, dialysis, chronic renal insufficiency [section 4]. [NAPRTCS website]. 2002; page 10. Available at: http://spitfire.emmes.com/study/ped/annlrept/index.htm. Accessed January 8, 2003.
23. Ojo AO, Meier-Kriesche HU, Hanson JA, et al. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation. 2000; 69: 2405-2409.
24. Humar A, Hassoun A, Kandaswamy R, et al. Immunologic factors: the major risk for decreased long-term renal allograft survival. Transplantation 1999; 68: 1842-1846.
25. Weber LT, Shipkova M, Armstrong VW, et al. The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: a report of the German study group on mycophenolate mofetil therapy. J Am Soc Nephrol 2002; 13(3): 759-768.
26. Houde I, Isenring P, Boucher D, et al. Mycophenolate mofetil, an alternative to cyclosporine A for long-term immunosuppression in kidney transplantation? Transplantation 2000; 70: 1251-1253.
27. Bunchman T, Navarro M, Broyer M, et al. The use of mycophenolate mofetil suspension in pediatric renal allograft recipients. Pediatr Nephrol 2001; 16: 978-984.
28. Tejani A. Post-transplant hypertension and hypertensive encephalopathy in renal allograft recipients. Nephron 1983; 34: 73-78.
29. Broyer M, Guest G, Gagnadoux MF, et al. Hypertension following renal transplantation in children. Pediatr Nephrol: 1987; 1: 16-21.
30. Gordjani N, Offner G, Hoyer PF, et al. Hypertension after renal transplantation in patients treated with cyclosporin and azathioprine. Arch Dis Child 1990; 65: 275-279.